Finance

Lists
Why is XPEV up 3.66%?
Dive Deeper
XPEV:NYSE
Xpeng Inc - ADR
$9.90
+3.66%
(+0.35) 1D
$9.92
+0.17% (+0.017)
After hours
Closed: Oct 9, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XPEV...
Open
$9.85
High
$10.12
Low
$9.83
Mkt. cap
9.51B
Avg. vol.
6.47M
Volume
11.02M
52-wk high
$28.24
52-wk low
$9.18
EPS
-$0.49
Beta
1.07
Shares outstanding
785.11M
No. of employees
21K
Open
$9.85
High
$10.12
Low
$9.83
Mkt. cap
9.51B
Avg. vol.
6.47M
Volume
11.02M
52-wk high
$28.24
52-wk low
$9.18
EPS
-$0.49
Beta
1.07
Shares outstanding
785.11M
No. of employees
21K
News stories
From web sources and news partners
About Xpeng Inc - ADR
CEO-
Employees20.6K
Founded2015
Headquarters-
SectorCar
Websitexiaopeng.com
Analyst ratings
Based on 9 analysts giving stock ratings to XPEV in the past 3 months
Buy
Buy
5
Hold
3
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for XPEV in the last 3 months.
Highest
Current $9.90
$28.00 (+182.83%)
Average
$17.88 (+80.61%)
Lowest
$11.50 (+16.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Nick Lai
J.P. Morgan
Hold
Downgraded
$11.50
+16.2%
09/29/2026
Paul Gong
UBS
Hold
Reiterated
$12.00
+21.2%
09/09/2026
Jiong Shao
Barclays
Sell
Reiterated
$14.00
+41.4%
08/25/2026
Jeff Chung
Citi
Buy
Maintained
$21.40
+116.2%
08/24/2026
Ji Shi
CMB International Securities
Buy
Maintained
$16.00
+61.6%
08/25/2026
Unknown Analyst
DBS
Buy
Maintained
$28.00
+182.8%
08/25/2026
Ming-Hsun Lee
Bank of America Securities
Buy
Reiterated
$18.00
+81.8%
08/24/2026
Neil Beveridge
Bernstein
Hold
Maintained
$20.00
+102%
08/17/2026
Unknown Analyst
UBS
Hold
Maintained
-
-
08/12/2026
Unknown Analyst
Goldman Sachs
Buy
Maintained
$20.00
+102%
08/03/2026
Eugene Hsiao
Macquarie
Buy
Upgraded
$19.00
+91.9%
05/28/2026
Eunice Lee
Bernstein
Hold
Maintained
$22.00
+122.2%
05/11/2026
Johnson Wan
Jefferies
Buy
Reiterated
$26.50
+167.7%
03/25/2026
Unknown Analyst
Jefferies
Buy
Reiterated
$26.50
+167.7%
03/25/2026
Bo Pei CFA
US Tiger Securities
Hold
Downgraded
$20.00
+102%
03/20/2026
Tim Hsiao
Morgan Stanley
Buy
Maintained
$34.00
+243.4%
03/09/2026
Last report
Aug 24, 2026
Fiscal period
Q2 2026
-CN¥1.29 / -CN¥0.76
-68.63%miss
Revenue / Est. (CNY)
19.74B / 20.50B
-3.67%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
20.38B
22.25B
13.03B
19.74B
Cost of goods sold
16.28B
17.40B
10.35B
15.66B
Cost of revenue
16.28B
17.40B
10.35B
15.66B
Research and development expenses
2.43B
2.87B
2.91B
2.91B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.49B
2.79B
1.88B
2.50B
Operating expense
4.78B
4.83B
4.61B
5.27B
Total operating expenses
21.06B
22.23B
14.96B
20.93B
Operating income
-677.22M
24.47M
-1.93B
-1.19B
Other non operating income
-1.11M
22.17M
-1.06M
49.37M
EBT including unusual items
-387.98M
405.34M
-1.77B
-1.26B
EBT excluding unusual items
-445.27M
208.70M
-2.00B
-1.17B
Income tax expense
-7.11M
22.13M
9.25M
74.28M
Effective tax rate
1.83%
5.46%
-0.52%
-5.88%
Other operating expenses
-140.28M
-839.69M
-182.25M
-137.25M
Net income
-380.87M
383.21M
-1.78B
-1.34B
Net profit margin
-1.87%
1.72%
-13.69%
-6.77%
Earnings per share
-0.16
0.52
-0.88
-0.65
Interest and investment income
300.84M
262.92M
257.17M
216.75M
Interest expense
-99.35M
-76.48M
-164.99M
-124.47M
Net interest expenses
201.49M
186.43M
92.17M
92.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-137.40M
593.24M
-1.36B
-621.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps